We are frequently asked how Cansema works -- in other words, how does it eliminate cancer cells while leaving healthy cells alone.
Expressed in its simplest terms, Cansema affects the cell membrane of cancer cells in such a way that the body's immune system (in both human and veterinary cases) recognizes the cancer as invasive. When cancer cells are so identified, the immune system initiates a process to kill the "invading cells." Cansema does not have this effect on normal cells.
This explains why the "application area" is so immunologically active -- with an inflammation response, slight edema, rubifacience (reddening of the skin surface), and a warming of the area. An laboratory analysis of an ejected eschar will show that in addition to dead cancer cells and dried serous fluid, there is the detritus of dead immune cells as well (i.e. granulocytes, neurophils, etc.)
This also explains why the internal protocols for Cansema do not work as well on patients who have highly compromised immune systems -- most notably those who have been through extensive chemotherapy and radiation, which are both incriminate killers of cells.

Cathryn Caton, N.D.
Alpha Omega Labs
Guayaquil, Ecuador